Administration of neutralizing antibodies of Hsp70 and Hsp90 to Apcmin/+ mice from 16 to 20 weeks of age attenuated muscle catabolism (Fig. 3a) and development of muscle wasting (Fig. 3b), without altering tumor burden (Supplementary Fig. 4A). This evidence concerns the gene HSP90AA1 and neoplasm.